BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 1511608)

  • 1. Cervical softening with mifepristone (RU 486) after pretreatment with naproxen. A double-blind randomized study.
    Rådestad A; Bygdeman M
    Contraception; 1992 Mar; 45(3):221-7. PubMed ID: 1511608
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pre-operative cervical preparation before first trimester vacuum aspiration: a randomized controlled comparison between gemeprost and mifepristone (RU 486).
    Henshaw RC; Templeton AA
    Br J Obstet Gynaecol; 1991 Oct; 98(10):1025-30. PubMed ID: 1751434
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of mifepristone on dilatation of the pregnant and non-pregnant cervix.
    Gupta JK; Johnson N
    Lancet; 1990 May; 335(8700):1238-40. PubMed ID: 1971320
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Induced cervical ripening with mifepristone (RU 486) and bioconversion of arachidonic acid in human pregnant uterine cervix in the first trimester. A double-blind, randomized, biomechanical and biochemical study.
    Rådestad A; Bygdeman M; Green K
    Contraception; 1990 Mar; 41(3):283-92. PubMed ID: 2182288
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of progesterone antagonist RU486 (mifepristone) for pre-operative cervical dilatation during first trimester abortion.
    Durlot F; Dubois C; Brunerie J; Frydman R
    Hum Reprod; 1988 Jul; 3(5):583-4. PubMed ID: 3170699
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mifepristone (RU 486) for cervical priming prior to surgically induced abortion in the late first trimester.
    Urquhart DR; Templeton AA
    Contraception; 1990 Aug; 42(2):191-9. PubMed ID: 2085969
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pretreatment of the primigravid uterine cervix with mifepristone 30 h prior to termination of pregnancy: a double blind study.
    Cohn M; Stewart P
    Br J Obstet Gynaecol; 1991 Aug; 98(8):778-82. PubMed ID: 1911585
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cervical ripening with mifepristone (RU 486) in first trimester abortion. An electron microscope study.
    Rådestad A; Thyberg J; Christensen NJ
    Hum Reprod; 1993 Jul; 8(7):1136-42. PubMed ID: 8408500
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Oral administration of an antiprogesterone (Mifepristone, RU 486) for preparing the cervix uteri for pregnancy interruption during the first trimester].
    De Grandi P; Giudici G
    J Gynecol Obstet Biol Reprod (Paris); 1989; 18(6):801-8. PubMed ID: 2689506
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Production of 12-hydroxyeicosatetraenoic acid in early pregnant uterine cervix--lack of correlation to mifepristone-induced cervical ripening. A double-blind randomized biomechanical and biochemical study.
    Heidvall K; Radestad A; Christensen NJ; Lindgren JA
    Prostaglandins; 1992 May; 43(5):473-82. PubMed ID: 1584996
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Induced cervical ripening with Mifepristone in first trimester abortion. A double-blind randomized biomechanical study.
    Rådestad A; Christensen NJ; Strömberg L
    Contraception; 1988 Sep; 38(3):301-12. PubMed ID: 3168450
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Are prostaglandins mediators of mifepristone (RU 486)-induced cervical softening in early pregnancy?
    Rådestad A; Bygdeman M
    J Lipid Mediat; 1993; 6(1-3):503-7. PubMed ID: 8358009
    [No Abstract]   [Full Text] [Related]  

  • 13. Should we use prostaglandins, tents or progesterone antagonists for cervical ripening before first trimester abortion?
    Gupta JK; Johnson N
    Contraception; 1992 Nov; 46(5):489-97. PubMed ID: 1458895
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cervical smooth muscle contractile activity after treatment with mifepristone and progesterone.
    Bokström H; Norström A; Rdestad A
    Contraception; 1994 Feb; 49(2):115-23. PubMed ID: 8143451
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cervical mucus concentration of prostaglandins E2 and F2 alpha after pretreatment with mifepristone in the first trimester of pregnancy.
    Bokström H; Norström A; Wiqvist N
    Prostaglandins; 1995 Jan; 49(1):41-8. PubMed ID: 7792390
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mifepristone: new preparation. Avoids or facilitates cervical dilatation before vacuum aspiration of pregnancy.
    Prescrire Int; 2001 Oct; 10(55):135-40. PubMed ID: 11824427
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pretreatment with mifepristone (RU 486) reduces interval between prostaglandin administration and expulsion in second trimester abortion.
    Rodger MW; Baird DT
    Br J Obstet Gynaecol; 1990 Jan; 97(1):41-5. PubMed ID: 2407284
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mifepristone versus vaginally administered misoprostol for cervical priming before first-trimester termination of pregnancy: a randomized, controlled study.
    Ashok PW; Flett GM; Templeton A
    Am J Obstet Gynecol; 2000 Oct; 183(4):998-1002. PubMed ID: 11035353
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mifepristone (RU486) and therapeutic late pregnancy termination: a double-blind study of two different doses.
    Frydman R; Fernandez H; Pons JC; Ulmann A
    Hum Reprod; 1988 Aug; 3(6):803-6. PubMed ID: 3065355
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of mifepristone and progesterone on collagen synthesis in the human uterine cervix.
    Bokström H; Norström A
    Contraception; 1995 Apr; 51(4):249-54. PubMed ID: 7796591
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.